Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YN001 in Adults With Coronary Atherosclerosis
NCT07521007Phase 2Recruiting
- Sponsor
- Beijing Inno Medicine Co., Ltd.
- Start
- Jul 2026
- Primary completion
- Jul 2027
- Modality
- Nanoparticles, Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of YN001 in Coronary atherosclerosis (CAD), sponsored by Beijing Inno Medicine Co., Ltd.. Started Jul 2026; status: recruiting.
02
Drugs
YN001
03
Conditions
Coronary atherosclerosis (CAD)
Beyond the preview
Go deeper on NCT07521007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07521007.